|40.15||-0.5300||-1.30%||Vol 21.29M||1Y Perf 20.48%|
|Jun 11th, 2021 16:02 DELAYED|
|- -||0.01 0.02%|
|Target Price||42.29||Analyst Rating||Moderate Buy 2.00|
|Potential %||5.33||Finscreener Ranking||★★ 46.44|
|Insiders Trans % 3/6/12 mo.||-100/-100/54||Value Ranking||★★★ 52.66|
|Insiders Value % 3/6/12 mo.||-100/-100/-78||Growth Ranking||★★★ 53.70|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-76||Income Ranking||★★★+ 49.93|
|Market Cap||224.75B||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||74.46||Earnings Date||27th Jul 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||27th Jul 2021|
|Estimated EPS Next Report||0.98|
|EPS Growth Next 5 Years %||7.60|
|Avg. Weekly Volume||26.31M|
|Avg. Monthly Volume||22.45M|
|Avg. Quarterly Volume||27.36M|
Pfizer Inc. (NYSE: PFE) stock closed at 40.15 per share at the end of the most recent trading day (a -1.3% change compared to the prior day closing price) with a volume of 21.38M shares and market capitalization of 224.75B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 78500 people. Pfizer Inc. CEO is Albert Bourla.
The one-year performance of Pfizer Inc. stock is 20.48%, while year-to-date (YTD) performance is 9.07%. PFE stock has a five-year performance of 14.72%. Its 52-week range is between 31.61 and 43.08, which gives PFE stock a 52-week price range ratio of 74.46%
Pfizer Inc. currently has a PE ratio of 19.90, a price-to-book (PB) ratio of 3.19, a price-to-sale (PS) ratio of 4.91, a price to cashflow ratio of 14.00, a PEG ratio of 2.32, a ROA of 6.63%, a ROC of 11.04% and a ROE of 16.17%. The company’s profit margin is 25.15%, its EBITDA margin is 35.70%, and its revenue ttm is $44.46 Billion , which makes it $7.94 revenue per share.
Of the last four earnings reports from Pfizer Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.98 for the next earnings report. Pfizer Inc.’s next earnings report date is 27th Jul 2021.
The consensus rating of Wall Street analysts for Pfizer Inc. is Moderate Buy (2), with a target price of $42.29, which is +5.33% compared to the current price. The earnings rating for Pfizer Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Pfizer Inc. has a dividend yield of 4.00% with a dividend per share of $1.56 and a payout ratio of 122.00%.
Pfizer Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 6.10, ATR14 : 0.66, CCI20 : 93.74, Chaikin Money Flow : -0.18, MACD : 0.28, Money Flow Index : 37.87, ROC : 2.08, RSI : 59.22, STOCH (14,3) : 74.67, STOCH RSI : 0.64, UO : 54.28, Williams %R : -25.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Pfizer Inc. in the last 12-months were: Albert Bourla (Option Excercise at a value of $4 939 038), Albert Bourla (Sold 132 508 shares of value $5 557 385 ), Alexander R. Mackenzie (Option Excercise at a value of $666 879), Angela Hwang (Option Excercise at a value of $740 235), Douglas M. Lankler (Option Excercise at a value of $3 490 011), Frank A. D'Amelio (Option Excercise at a value of $7 153 459), Jennifer B. Damico (Option Excercise at a value of $506 551), Jennifer B. Damico (Sold 2 500 shares of value $102 050 ), John Douglas Young (Option Excercise at a value of $6 631 229), Payal Sahni (Option Excercise at a value of $228 488), Rady A. Johnson (Option Excercise at a value of $1 424 429), Ronald E. Blaylock (Buy at a value of $924 790), Sally Susman (Option Excercise at a value of $3 476 299), Sally Susman (Sold 43 662 shares of value $1 831 184 ), William R. Carapezzi (Option Excercise at a value of $1 105 201)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.